Can a nonviolent communication program help adults with schizophrenia communicate more effectively?
| ISRCTN | ISRCTN18284927 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN18284927 |
| Sponsor | Chungnam National University |
| Funder | Investigator initiated and funded |
- Submission date
- 18/11/2026
- Registration date
- 18/11/2026
- Last edited
- 18/11/2026
- Recruitment status
- No longer recruiting
- Overall study status
- Ongoing
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
Some people with schizophrenia find it hard to express what they need or to talk through disagreements. This study asks whether adding group communication training to usual care helps adults with schizophrenia communicate more effectively. It also looks at changes in pulse measurements relating to stress and in psychiatric symptoms.
Who can participate?
Patients aged 19 to 64 years who had a diagnosis of schizophrenia and were receiving care at one of two psychiatric hospitals or two community mental health centres in South Korea. They needed to have taken their prescribed antipsychotic medication consistently for 3 months and to be able to read and answer a questionnaire themselves.
What does the study involve?
Each hospital or centre was assigned by chance to one of two groups. Everyone continued their usual care. People at the two training sites were offered ten 1-hour group sessions. They practised describing what happened, talking about feelings and needs, making requests, and listening to others. At three visits, participants are asked to complete a communication questionnaire, speak with a trained assessor and wear a clip on one earlobe for a 1-minute pulse recording. The visits take place before training, just after it ends and 4 weeks later.
What are the possible benefits and risks of participating?
The group sessions offer practice in expressing feelings and needs and in listening to other people. How much this helps is uncertain. Talking about personal experiences may feel uncomfortable. The ear clip may cause brief discomfort. Participants can take a break or stop taking part at any time. Their usual care continues.
Where is the study run from?
Chungnam National University (South Korea)
When is the study starting and how long is it expected to run for?
August 2026 to November 2026
Who is funding the study?
Investigator initiated and funded
Who is the main contact?
Hong gyu Park, hgdear@gmail.com
Contact information
Principal investigator
College of Nursing, Chungnam National University, 266 Munhwa-ro, Jung-gu
Daejeon
35015
Korea, South
| Phone | +82 (0)42 580 8332 |
|---|---|
| mhgang@cnu.ac.kr |
Scientific, Public
College of Nursing, Chungnam National University, 266 Munhwa-ro, Jung-gu
Daejeon
35015
Korea, South
| Phone | +82 (0)10 7632 0524 |
|---|---|
| hgdear@gmail.com |
Study information
| Primary study design | Interventional |
|---|---|
| Allocation | Randomized controlled trial |
| Masking | Blinded (masking used) |
| Control | Active |
| Assignment | Parallel |
| Purpose | Treatment |
| Scientific title | A cluster-randomised controlled trial of nonviolent communication program for communication skills, stress and psychiatric symptoms in adults with schizophrenia |
| Study objectives | To assess whether adding a nonviolent communication programme to usual care improves communication skills in adults with schizophrenia compared with usual care alone. Secondary objectives are to assess changes in physiological measures related to stress and in psychiatric symptom severity. |
| Ethics approval(s) |
Approved 02/06/2026, Chungnam National University Institutional Review Board (Room 301, Administration Building Annex (E7-1), Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Korea, South; +82 (0)42 821 5293; irb@cnu.ac.kr), ref: 202511-SB-228-01 |
| Health condition(s) or problem(s) studied | Schizophrenia |
| Intervention | The institution was the unit of randomisation. Sealed Envelope’s online randomisation tool (https://www.sealedenvelope.com/) was used to randomise the four participating institutions. Randomisation was stratified by institution type. The two psychiatric hospitals formed one stratum, and the two community mental health welfare centres formed the other. Within each stratum, one institution was allocated to the nonviolent communication program plus usual care and the other to usual care alone. Individual participants were subsequently recruited into the study arm assigned to their institution. The intervention arm received a group nonviolent communication programme in addition to usual care. Ten 60-minute sessions were delivered between 18 August and 27 October 2026. The programme manual uses discussion, paired practice and role-play to teach participants to describe observations, express feelings, identify needs, make requests and listen to others with empathy. The control arm continued the usual care provided by its institution during the study. Both arms followed the same assessment schedule. Outcome assessors were blinded to group allocation. Participants and intervention providers knew the allocation. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) |
|
| Completion date | 24/11/2026 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Adult |
| Lower age limit | 19 Years |
| Upper age limit | 64 Years |
| Sex | All |
| Target sample size at registration | 36 |
| Total final enrolment | 36 |
| Key inclusion criteria | 1. Aged 19 to 64 years and either admitted to a psychiatric ward at a participating hospital or registered with a participating community mental health welfare centre 2. Schizophrenia diagnosed by a psychiatrist according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria 3. Stable use of prescribed antipsychotic medication for the preceding 3 months, as confirmed by the treating physician. 4. Able to communicate and to read and answer the questionnaire independently 5. Voluntary written informed consent from the participant, with written consent from the representative specified in the protocol |
| Key exclusion criteria | 1. Comorbid intellectual disability or an organic mental disorder 2. Unstable symptoms that impeded group participation. This criterion required at least one of the following in the preceding 2 weeks 2.1. Close observation for a high risk of harm to self or others, as judged by the treating physician 2.2. Documented severe agitation or aggression requiring seclusion, restraint or emergency intervention 2.3. Acute psychotic deterioration with a Brief Psychiatric Rating Scale score of 6 or higher on hallucinatory behaviour or unusual thought content 2.4. Delirium, disorientation, severe thought disorganisation, catatonia, substance intoxication or withdrawal that prevented communication or group participation, as judged by the physician or documented in the clinical record 3. Diagnosed hypertension or cardiovascular disease that could affect heart rate variability, with related treatment or medication within the preceding 6 months |
| Date of first enrolment | 14/08/2026 |
| Date of final enrolment | 14/08/2026 |
Locations
Countries of recruitment
- Korea, South
Study participating centres
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan | Researchers may request anonymised participant-level data underlying the published findings from Professor Moonhee Gang (mhgang@cnu.ac.kr). Each request will be considered individually. Data may be released only after the required written consent for third-party sharing and ethics review have been obtained. |
Editorial Notes
18/11/2026: Study's existence confirmed by the Chungnam National University Institutional Review Board.